Does itraconazole improve quality of life in severe asthma with fungal sensitization?

N. Khazeni,J. Levitt

DOI: https://doi.org/10.1164/AJRCCM.180.2.191A

IF: 24.7

2009-07-15

American Journal of Respiratory and Critical Care Medicine

Abstract:

What problem does this paper attempt to address?

Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial

Omar Dzaye,Alexander C Razavi,Erin D Michos,Martin Bødtker Mortensen,Zeina A Dardari,Khurram Nasir,Albert D Osei,Allison W Peng,Ron Blankstein,John H Page,Michael J Blaha

DOI: https://doi.org/10.1016/j.atherosclerosis.2022.02.006

IF: 5.3

Atherosclerosis

Abstract:Background and aims: Coronary artery calcium (CAC) burden displays a stepwise association with atherosclerotic cardiovascular disease (ASCVD) risk. Among primary prevention patients, we sought to determine the CAC scores equivalent to ASCVD mortality rates observed in the FOURIER trial, a modern secondary prevention cohort. Methods and results: For the main analysis, we included participants from the CAC Consortium ≥50 years old with a 10-year ASCVD risk ≥7.5% (n = 20,207). Poisson regression was used to define the relationship between CAC and annual ASCVD mortality. Equations generated from the regression models were then used to derive CAC scores associated with equivalent annual ASCVD mortality as observed in FOURIER placebo participants from the overall trial and in key trial subgroups. The CAC Consortium participants had a similar age (65.5 versus 62.5 years) and sex (22% versus 24% female) distribution as FOURIER. The annualized ASCVD mortality rate in FOURIER participants (0.766 per 100 person-years) corresponded to a CAC score of 781 (418-1467). A CAC score of 255 (162-394) corresponded to an ASCVD mortality rate equivalent to the lowest risk FOURIER subgroup (presence of myocardial infarction >2 years prior to trial enrollment). No CAC score produced a risk equivalent to high-risk FOURIER subgroups, particularly those with symptomatic peripheral arterial disease and/or multivessel coronary heart disease. Conclusions: Primary prevention individuals with increased CAC burden may have annualized ASCVD mortality rates equivalent to persons with stable secondary prevention-level risk. These findings argue for a risk continuum between higher risk primary prevention and stable secondary prevention patients, as their ASCVD risks may overlap.
Coronary Artery Calcium for Risk Stratification Among Persons With Very High HDL Cholesterol

Alexander C Razavi,Anurag Mehta,Nathan D Wong,Alan Rozanski,Matthew J Budoff,Eugenia Gianos,Viola Vaccarino,Marly van Assen,Carlo N De Cecco,Michael D Miedema,John A Rumberger,Martin Bødtker Mortensen,Leslee J Shaw,Khurram Nasir,Roger S Blumenthal,Anand Rohatgi,Arshed A Quyyumi,Laurence S Sperling,Seamus P Whelton,Michael J Blaha,Daniel S Berman,Omar Dzaye

DOI: https://doi.org/10.1016/j.jacadv.2024.101217

2024-08-29

Abstract:Background: Compared to normal high-density lipoprotein (HDL) cholesterol values, very high HDL cholesterol is associated with a higher incidence of mortality and atherosclerotic cardiovascular disease (ASCVD). As such, clinical risk stratification among persons with very high HDL cholesterol is challenging. Objectives: Among persons with very high HDL cholesterol, the purpose was to determine the prevalence of coronary artery calcium (CAC) and compare the association between traditional risk factors vs CAC for all-cause mortality and ASCVD. Methods: The primary analysis was completed among 446 participants from the Cedars-Sinai Medical Center of the CAC Consortium with very high HDL cholesterol (≥77 mg/dL in men, ≥97 mg/dL in women). Cox proportional hazards regression assessed the association of CAC and traditional risk factors with all-cause mortality during a median follow-up of 10.7 years. Replication and validation analyses were performed for all-cause mortality among 119 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) with very high HDL cholesterol, who also had information on incident ASCVD. Results: The mean age was 57.9 years old, 49% were women, and the median HDL cholesterol was 98 mg/dL. One-half of participants (50%) had prevalent CAC, in whom the median CAC score was 118. Prevalent CAC conferred a 3.6-fold higher risk of all-cause mortality (HR: 3.64; 95% CI: 1.21-11.01), which appeared to be a more robust predictor than individual traditional risk factors beyond age. In the validation sample, prevalent CAC but not individual traditional risk factors were associated with all-cause mortality (HR: 2.39; 95% CI: 1.07-5.34) and a 4.0-fold higher risk of ASCVD (HR: 4.06; 95% CI: 1.11-14.84). Conclusions: Measurement of CAC may facilitate clinical risk assessment among individuals with very high HDL cholesterol.
Association between coronary artery calcium score on non-contrast chest computed tomography and all-cause mortality among patients with congestive heart failure

Kyoko Ota,Rine Nakanishi,Hidenobu Hashimoto,Yuriko Okamura,Ippei Watanabe,Takayuki Yabe,Ryo Okubo,Takanori Ikeda

DOI: https://doi.org/10.1007/s00380-021-01906-y

Abstract:Coronary artery calcium (CAC) score is a robust prognostic tool to predict cardiac events. Although patients with congestive heart failure (CHF) occasionally undergo non-contrast computed tomography (NCCT), the prognostic utility of CAC by NCCT is not widely known. We aimed to determine if CAC measured on NCCT is associated with all-cause mortality (ACM) among patients with CHF. We identified 550 patients admitted due to CHF who underwent NCCT. Patients were categorized into three groups according to CAC scores 0, 1-999, and ≥ 1000. The multivariate Cox proportional hazards model was used to assess if CAC by NCCT was associated with ACM after adjusting for traditional coronary artery disease (CAD) risk factors, brain natriuretic peptide and left ventricular ejection fraction (LVEF). In a subset of 245 patients with invasive coronary angiography (ICA), the associations between CAC scores and ACM were assessed in the multivariate Cox proportional hazards model. Further, we assessed if CAC increased statin use at discharge. During a mean follow-up of 3.3 ± 3.1 years, ACM occurred in 168 patients (30.55%). Compared with patients with CAC 0, those with CAC ≥ 1000 (HR 1.564, 95% CI 0.969-2.524, P = 0.067) were more likely to experience ACM, while those with CAC score 1-999 (HR 0.971, 95% CI 0.673-1.399, P = 0.873) were not. Similarly, a trend toward significance was observed in patients with LVEF < 40% (HR 2.124, 95% CI 0.929-4.856, P = 0.074). In the sub-analysis, patients with CAC ≥ 1000 had increased ACM compared to those with CAC 0, only if ICA ≥ 50% (HR 3.668, 95% CI 1.141-11.797, P = 0.029). Multivariate logistic regression revealed that statin use at discharge was increased with ICA ≥ 50%, but not CAC. The CAC score measured by NCCT tended to be associated with ACM among CHF patients. Statin use was not increased by CAC on NCCT.
The utility of coronary artery calcium in non-gated high resolution CT thorax scans in predicting cardiac events as compared to the Framingham risk score: a retrospective study

S Saluja,H Contractor,M Daniells,J Sobolewska,K Khan,L Mitchell,S Saluja,X Jiang,S.G Anderson

DOI: https://doi.org/10.1093/ehjci/ehaa946.0172

IF: 39.3

2020-11-01

European Heart Journal

Abstract:Abstract Background There is existing evidence to suggest a correlation between coronary artery calcification (CAC) measured using ECG-triggered chest computed tomography and cardiovascular disease. Further evidence has emerged to suggest a correlation between CAC measured using non-gated CT scans and cardiovascular disease. Herein, we sought to ascertain the utility of incidental findings of CAC on non-triggered high resolution CT (HRCT) thorax used for patients undergoing lung cancer screening or follow-up for interstitial lung disease and Framingham risk score (FRS) in predicting cardiovascular events. Methods The Computerised Radiology Information Service (CRIS) database was manually searched to determine all HRCT scans performed in a single trust from 05/2015 to 05/2016. The reports issued by Radiologists and images of selected studies were reviewed. For patients with CAC, we calculated the calcium score for patients using the Agatston method. Clinical events were determined from the electronic medical record without knowledge of patients' CAC findings. For these patients, the Framingham Risk Score (FRS) was also calculated. The primary end point of the study was composite of all-cause mortality and cardiac events (non-fatal myocardial infarction, coronary revascularization, new atrial fibrillation or heart failure episode requiring hospitalization). Results We selected 300 scans from a total of approximately 2000 scans performed over this time. Data at follow up was available for 100% of the patients, with a median duration of follow up of 1.6 years. Moderate to severe CAC was found in 35% of people. Multivariable analysis showed good concordance between CAC and FRS in predicting composite clinical end point. The Odds Ratio for cardiac events in patients with moderate to severe CAC was 5.3 (p<0.01) and for composite clinical end point was 3.4 (p<0.01). This is similar to the OR predicted by the FRS: 4.8; p<0.01 and 3.1; p<0.01 respectively. Only 6.2% of patients with moderate to severe CAC were currently statin treated. Conclusion In this retrospective study of patients with respiratory disease attending for HRCT scanning, co-incidentally detected CAC predicts cardiac events, with good concordance with the FRS. The incidental finding of CAC on non-gated CT scanning should be reported with Agatston score calculation allowing consideration of intervention to mitigate cardiovascular risk and optimize. Further multi-centre prospective studies of this strategy, with a larger patient cohort should be conducted to clarify the utility of CAC as a prediction tool to modify cardiac risk. Funding Acknowledgement Type of funding source: None

cardiac & cardiovascular systems
Interplay between Risk Factors and Coronary Artery Calcium in Middle-Aged and Elderly Symptomatic Patients

Lu Zeng,Jun-Yi Luo,Fen Liu,Zhuo-Ran Zhang,Ya-Jing Qiu,Fan Luo,Xin-Xin Tian,Xiao-Mei Li,Yi-Ning Yang

DOI: https://doi.org/10.31083/j.rcm2406158

2023-06-06

Reviews in Cardiovascular Medicine

Abstract:Background: The prognostic value of coronary artery calcium (CAC) combined with risk factor burdens in middle-aged and elderly patients with symptoms is unclear. Methods: A cohort study comprising 7432 middle-aged and elderly symptomatic patients (aged above 55 years) was conducted between December 2013 and September 2020. All patients had undergone coronary computed tomography angiography, and the Agatston score were used to measure CAC scores. The primary outcome was major adverse cardiac and cerebrovascular events (MACCE), which was defined as a composite outcome of nonfatal myocardial infarction, revascularization (percutaneous coronary intervention or coronary artery bypass graft), stroke, and cardiovascular death. Congestive heart failure, cardiogenic shock, malignant arrhythmia, and all-cause mortality were defined as the secondary outcomes. Results: There are 970 (13%) patients with CAC 0–10, 2331 (31%) patients with CAC 11–100, and 4131 (56%) patients with CAC ≥101. The proportion of patients aged 55–65 years, 65–75 years and ≥75 years was 40.7%, 38.1% and 21.2%, respectively. The total number of MACCEs over the 3.4 years follow-up period was 478. The percentage of CAC ≥101 was higher among the 75-year-old group than the 55–65-year-old group, increasing from 46.5% to 68.2%. With the increase in the CAC score, the proportion of patients aged ≥75 years increased from 12.9% to 25.8%, compared to those aged 55–65 years. The number of risk factors gradually increased as the CAC scores increased in the symptomatic patients aged over 55 years and the similar tendencies were observed among the different age subgroups. The proportion of non-obstructive coronary artery disease (CAD) was comparable between the three age groups (53.5% vs 51.9% vs 49.1%), but obstruction CAD increased with age. The incidence of MACCE in the group with CAC ≥101 and ≥4 risk factors was 1.71 times higher (95% confidence interval (CI) 1.01–2.92; p = 0.044) than the rate in the group with CAC ≥101 and 1 risk factor. In the CAC 0–10 group, the incidence of MACCE in patients aged ≥75 years was 12.65 times higher (95% CI: 6.74–23.75; p < 0.0001) than that in patients aged 55–65 years. By taking into account the combination of CAC score, age, and risk factor burden, the predictive power of MACCE can be increased (area under the curve (AUC) = 0.614). Conclusions: In symptomatic patients aged 55 or above, a rise in age, CAC scores, and risk factor burden was linked to a considerable risk of future MACCE. In addition, combining CAC scores, age and risk factors can more accurately predict outcomes for middle-aged and elderly patients with symptoms.

cardiac & cardiovascular systems
Electrohydraulic waves (Urat I) for the treatment of vesical calculi

D. Albrecht,R. Nagel,C. Kölln

DOI: https://doi.org/10.1007/BF02081892

IF: 2.2662

International Urology and Nephrology

Abstract:
The role of coronary artery calcium score and european score2 in primary prevention of cardiovascular disease

G Ferrante,F Catapano,B Bacallao,I Romano,V Di Stefano,A Celata,V Battaglia,S Carli,G Del Monaco,F Gioia,F Amata,A Latini,C D'andrea,M Francone,G Condorelli

DOI: https://doi.org/10.1093/eurheartj/ehae666.2720

IF: 39.3

2024-10-29

European Heart Journal

Abstract:Background There is limited evidence about the role of using coronary artery calcium (CAC) score in conjunction with the European SCORE2 (systematic coronary risk evaluation) for the identification of individuals at higher risk of cardiovascular disease. Purpose To evaluate the relationship between CAC score and the European SCORE2 for cardiovascular risk stratification in an asymptomatic population in primary prevention. Methods This is a preliminary analysis from a single-centre, prospective, randomised 1:1, controlled trial assessing the use of CAC score vs standard preventive strategies in asymptomatic individuals undergoing primary cardiovascular prevention. The 10-year risk of cardiovascular events was assessed with either SCORE2 (ages 45-69) or SCORE2-OP (ages 70-89). Subjects were classified as 1) low to moderate risk, 2) high risk, and 3) very high risk according to SCORE2/SCORE2-OP. CAC score was assessed by ECG gated low-dose computed tomography with no contrast administration. A CAC score of zero was considered to reclassify risk one level downward in high or very-high risk patients. CAC score ≥ 100 was used to reclassify risk one level upward in patients with low to moderate risk and a CAC score > 1000 to reclassify risk upward in subjects with high risk. Results A total of 1,252 participants: 627 in the CAC group and 625 in the control group, median age 55 yrs, 25th-75th 50-61 yrs, with availability of SCORE2 and SCORE2-OP were included in this analysis. SCORE2/SCORE 2-OP was similar in the CAC and control groups. Among the subjects in the CAC group, there was a highly significant difference in SCORE2/SCORE 2-OP between participants with CAC score = zero and those with CAC > zero (median 5.6, 25th-75th 3.6-8.55 vs 2.9, 1.8-4.6, p< 0.001) as well as between those with CAC ≥ 100 and those with CAC score < 100 [median 6.8, 25th-75th (10.3-4.5) vs 3.3 (2.0-5.3), p<0.001]. The prevalence of CAC score = zero was 75% in the low to moderate risk group, 47% in the high risk, and 20% in the very high risk, p<0.001. By contrast the prevalence of CAC score ≥ 100 was 7% in the low to moderate risk group, 24% in the high risk, and 45% in the very high risk, p< 0.001. The proportion of patients classified as low to moderate risk group was 72% with CAC score vs 59% without CAC score, high risk 23% with CAC score vs 35% without CAC score, very high risk 5% vs 6% respectively, p<0.001. Using CAC score risk reclassification occurred in 48% downward and 2% upward in originally classified high risk subjects, 7% upward in originally classified low to moderate risk, and 20% downward in originally classified very high risk subjects. Conclusions CAC score may lead to risk reclassification in a substantial proportion of individuals, in particular among those originally classified as high risk by the SCORE2/SCORE2-OP. The cardiovascular risk prediction accuracy of adding CAC score to SCORE2/SCORE2-OP awaits validation at long-term follow-up.

cardiac & cardiovascular systems
Non-esterified fatty acids, serum insulin and blood glucose after a beta-receptor blocking agent in normal, hypophysectomized, diabetic and hypophysectomized-diabetic dogs.

J. Beyer,U. Cordes,E. Böhle,K. Schöffling

DOI: https://doi.org/10.1530/ACTA.0.072S123

1973-04-01

Abstract:
Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in Coronary Artery Calcium >1,000

Alexander C Razavi,Leslee J Shaw,Daniel S Berman,Matthew J Budoff,Nathan D Wong,Viola Vaccarino,Marly van Assen,Carlo N De Cecco,Arshed A Quyyumi,Anurag Mehta,Paul Muntner,Michael D Miedema,Alan Rozanski,John A Rumberger,Khurram Nasir,Roger S Blumenthal,Laurence S Sperling,Martin Bødtker Mortensen,Seamus P Whelton,Michael J Blaha,Omar Dzaye,Alexander C. Razavi,Leslee J. Shaw,Daniel S. Berman,Matthew J. Budoff,Nathan D. Wong,Carlo N. De Cecco,Arshed A. Quyyumi,Michael D. Miedema,John A. Rumberger,Roger S. Blumenthal,Laurence S. Sperling,Seamus P. Whelton,Michael J. Blaha

DOI: https://doi.org/10.1016/j.jcmg.2023.12.006

2024-02-01

Abstract:BACKGROUND: Although a coronary artery calcium (CAC) of ≥1,000 is a subclinical atherosclerosis threshold to consider combination lipid-lowering therapy, differentiating very high from high atherosclerotic cardiovascular disease (ASCVD) risk in this patient population is not well-defined.OBJECTIVES: Among persons with a CAC of ≥1,000, the authors sought to identify risk factors equating with very high-risk ASCVD mortality rates.METHODS: The authors studied 2,246 asymptomatic patients with a CAC of ≥1,000 from the CAC Consortium without a prior ASCVD event. Cox proportional hazards regression modelling was performed for ASCVD mortality during a median follow-up of 11.3 years. Crude ASCVD mortality rates were compared with those reported for secondary prevention trial patients classified as very high risk, defined by ≥2 major ASCVD events or 1 major event and ≥2 high-risk conditions (1.4 per 100 person-years).RESULTS: The mean age was 66.6 years, 14% were female, and 10% were non-White. The median CAC score was 1,592 and 6% had severe left main (LM) CAC (vessel-specific CAC ≥300). Diabetes (HR: 2.04 [95% CI: 1.47-2.83]) and severe LM CAC (HR: 2.32 [95% CI: 1.51-3.55]) were associated with ASCVD mortality. The ASCVD mortality per 100 person-years for all patients was 0.8 (95% CI: 0.7-0.9), although higher rates were observed for diabetes (1.4 [95% CI: 0.8-1.9]), severe LM CAC (1.3 [95% CI: 0.6-2.0]), and both diabetes and severe LM CAC (7.1 [95% CI: 3.4-10.8]).CONCLUSIONS: Among asymptomatic patients with a CAC of ≥1,000 without a prior index event, diabetes, and severe LM CAC define very high risk ASCVD, identifying individuals who may benefit from more intensive prevention therapies across several domains, including low-density lipoprotein-cholesterol lowering.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Comparative Value of Coronary Artery Calcium and Multiple Blood Biomarkers for Prognostication of Cardiovascular Events

Jamal S. Rana,Heidi Gransar,Nathan D. Wong,Leslee Shaw,Michael Pencina,Khurram Nasir,Alan Rozanski,Sean W. Hayes,Louise E. Thomson,John D. Friedman,James K. Min,Daniel S. Berman

DOI: https://doi.org/10.1016/j.amjcard.2012.01.358

IF: 3.133

2012-05-01

The American Journal of Cardiology

Abstract:The value of coronary artery calcium (CAC) scoring versus multiple biomarkers in increasing risk prediction for cardiovascular disease (CVD) remains unknown. The study group consisted of 1,286 asymptomatic participants (mean ± SD 59 ± 8 years old) with no known coronary heart disease. Mean follow-up time was 4.1 ± 0.4 years with the primary outcome of combined CVD (cardiac death, myocardial infarction, stroke, and late target vessel revascularization). CAC was calculated by the method of Agatston. Biomarkers measured were C-reactive protein, interleukin-6, myeloperoxidase, B-type natriuretic peptide, and plasminogen activator-1. During follow-up 35 participants developed CVD events including cardiac deaths (6%), myocardial infarction (23%), strokes (17%), and late revascularizations (54%). In Cox proportional-hazards models adjusted for Framingham Risk Score (FRS), presence of log CAC beyond FRS was associated with increased hazards for CVD events (hazard ratio 1.7, 95% confidence interval [CI] 1.4 to 2.0, p <0.001). Multiple biomarkers score was also associated with increased risk beyond FRS (hazard ratio 2.1, p = 0.02) per 1-U increase in score; however, the c-statistic did not increase significantly (0.75, 95% CI 0.68 to 0.84, p = 0.32). The c-statistic increased when log CAC was incorporated into FRS without or with multiple biomarkers score (c-statistic 0.84, p = 0.003 and p = 0.008 respectively). Addition of CAC to risk factors showed significant reclassification (net reclassification improvement 0.35 (95% CI 0.11 to 0.58, p = 0.007; integrated discrimination index 0.076, p = 0.0001), whereas addition of multiple biomarkers score did not show significant reclassification. In conclusion, in this study of asymptomatic subjects without known CVD, addition of CAC but not biomarkers substantially improved risk reclassification for future CVD events beyond traditional risk factors.

cardiac & cardiovascular systems
Synaptic processes in motor neurons during viscero-somatic reflexes

P. Duda,P. Kostyuk,N. N. Preobrazhenskii

DOI: https://doi.org/10.1007/BF00783324

IF: 0.737

1966-06-01

Bulletin of Experimental Biology and Medicine

Abstract:
Coronary artery calcium as a marker of healthy and unhealthy aging in adults aged 75 and older: The atherosclerosis risk in communities (ARIC) study

Olufunmilayo H. Obisesan,Ellen Boakye,Frances M. Wang,Zeina Dardari,Omar Dzaye,Miguel Cainzos-Achirica,Michelle L. Meyer,Rebecca Gottesman,Priya Palta,Josef Coresh,Candace M. Howard-Claudio,Frank R. Lin,Naresh Punjabi,Khurram Nasir,Kunihiro Matsushita,Michael J. Blaha

DOI: https://doi.org/10.1016/j.atherosclerosis.2024.117475

IF: 5.3

2024-02-14

Atherosclerosis

Abstract:Background and aims Coronary artery calcium (CAC) is validated for risk prediction among middle-aged adults, but there is limited research exploring implications of CAC among older adults. We used data from the Atherosclerosis Risk in Communities study to evaluate the association of CAC with domains of healthy and unhealthy aging in adults aged ≥75years. Methods We included 2,290 participants aged ≥75years free of known coronary heart disease who underwent CAC scoring at study visit 7. We examined the cross-sectional association of CAC = 0, 1–999(reference), and ≥1000 with seven domains of aging: cognitive function, hearing, ankle-brachial index (ABI), pulse-wave velocity (PWV), forced vital capacity (FVC), physical functioning, and grip strength. Results The mean age was 80.5 ± 4.3years, 38·6% male, and 77·7% White. 10·3% had CAC = 0 and 19.2% had CAC≥1000. Individuals with CAC = 0 had the lowest while those with CAC≥1000 had the highest proportion with dementia(2% vs 8%), hearing impairment(46% vs 67%), low ABI(3% vs 18%), high PWV(27% vs 41%), reduced FVC(34% vs 42%), impaired grip strength(66% vs 74%), and mean composite abnormal aging score(2.6 vs 3.7). Participants with CAC = 0 were less likely to have abnormal ABI(aOR:0.15, 95%CI:0.07–0.34), high PWV(aOR:0.57, 95%CI:0.41–0.80), and reduced FVC(aOR:0.69, 95%CI:0.50–0.96). Conversely, participants with CAC≥1000 were more likely to have low ABI(aOR:1.74, 95%CI:1.27–2.39), high PWV(aOR:1.52, 95%CI:1.15–2.00), impaired physical functioning(aOR:1.35, 95%CI:1.05–1.73), and impaired grip strength(aOR:1.46, 95%CI:1.08–1.99). Conclusion Our findings highlight CAC as a simple measure broadly associated with biological aging, with clinical and research implications for estimating the physical and physiological aging trajectory of older individuals.

cardiac & cardiovascular systems,peripheral vascular disease
Impact of coronary artery calcium on mortality and cardiovascular events in metabolic syndrome and diabetes among younger adults

Soroush Masrouri,Michael D Shapiro,Davood Khalili,Farzad Hadaegh

DOI: https://doi.org/10.1093/eurjpc/zwae039

IF: 8.526

2024-02-07

European Journal of Preventive Cardiology

Abstract:Abstract Aims Whether coronary artery calcium (CAC) testing in younger individuals with metabolic syndrome (MetS) and diabetes mellitus (DM) helps predict cardiovascular disease (CVD) and death independent of traditional risk factors (RFs) remains less clear. Methods and results We pooled data obtained from 5174 individuals aged 38–55 years from the CARDIA (Coronary Artery Risk Development in Young Adults; n = 3047, year 20) and MESA (Multi-Ethnic Study of Atherosclerosis; n = 2127, Visit 1) studies who completed computed tomography of CAC. The mean age (SD) of participants (44.7% men) was 47.3 (4.2) years. Multivariable Cox proportional hazards regression models were used to estimate hazard ratios (HRs) of CVD, coronary heart disease (CHD), and all-cause death. There were 1085 participants (21.0%) with prevalent CAC at baseline. A total of 461 (8.9%) had DM, 1025 (19.8%) had MetS without DM, and 3688 (71.3%) had neither condition. Over a median follow-up of 14.2 years, 256 (5.0%) participants died, and 304 (5.9%) CVD and 188 (3.6%) CHD events occurred. The CAC score was independently associated with incident CVD in those with DM (HR: 95% CI; 1.22: 1.08–1.38), MetS (1.18: 1.08–1.31), and neither condition (1.36: 1.26–1.46). The corresponding HRs for CAC ≥ 100 were 2.70 (1.25–5.83), 3.29 (1.87–5.79), and 6.30 (4.02–9.86), respectively. Similar associations for CHD and death were found. The impact of CAC ≥ 100 on CVD and CHD was lower in the presence of DM (P interaction < 0.05). The association of CAC with all outcomes in individuals with DM remained significant after adjusting with haemoglobin A1c levels. Conclusion Coronary artery calcium score is independently associated with cardiovascular events and death over nearly 15 years after screening at ages 38–55 years, with a less pronounced impact on CVD and CHD events in the presence of DM.

cardiac & cardiovascular systems
Association between coronary artery calcification score as assessed by multi-detector row computed tomography and cardiovascular risk factors

ZHANG Jian,HAN Ya-ling,JING Quan-min,WANG Xiao-zeng,LI Yi,ZHANG Lei,HUO Yong,ZHANG Yan

DOI: https://doi.org/10.3969/j.issn.1004-8812.2011.06.005

2011-01-01

Abstract:Objective The coronary artery calcification (CAC) score determined by multi-detector row computed tomography (MDCT) predicts the onset of coronary artery disease (CAD). In addition, cardiovascular risk factors also predict the mortality of CAD. Therefore, the aim of this study was to assess whether or not the CAC score is associated with cardiovascular risk factors. Methods A total of 9847 consecutive patients with suspected coronary artery disease underwent coronary angiography between January 2001 and March 2007 at 20 centers of China were enrolled. The subjects consisted of 311 consecutive patients with suspected CAD who underwent MDCT. The body mass index, blood pressure, blood glucose, and serum total cholesterol, triglyceride and low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were measured. Results When the patients were divided into three groups according to the CAC score [low (0-12 IU), intermediate (13-445) and high (≥446)], the classification score was significantly associated with age, prevalence of cardiovascular history and diabetes mellitus and HDL-C. In multivariate logistic regression analysis, age (P=0.013) and plasma levels of high-density lipoprotein cholesterol (P=0.020) remained significant independent variables for the classification. Conclusions Age, prevalence of cardiovascular history and diabetes mellitus and HDL-C were significantly associated with the classification according to the CAC score. The detection of CACS by MSCT could provide reliable and efective evidence for diagnosis of CHD in patients with cardiovascular risk factors.
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis

Jaideep Patel,Vincent A Pallazola,Ramzi Dudum,Philip Greenland,John W McEvoy,Roger S Blumenthal,Salim S Virani,Michael D Miedema,Steven Shea,Joseph Yeboah,Antonio Abbate,William G Hundley,Amy B Karger,Michael Y Tsai,Vasanth Sathiyakumar,Oluseye Ogunmoroti,Mary Cushman,Nazir Savji,Kiang Liu,Khurram Nasir,Michael J Blaha,Seth S Martin,Mahmoud Al Rifai

DOI: https://doi.org/10.1001/jamacardio.2021.2321

2021-10-01

Abstract:Importance: The 2018 American Heart Association/American College of Cardiology Guideline on the Management of Blood Cholesterol recommends the use of risk-enhancing factor assessment and the selective use of coronary artery calcium (CAC) scoring to guide the allocation of statin therapy among individuals with an intermediate risk of atherosclerotic cardiovascular disease (ASCVD). Objective: To examine the association between risk-enhancing factors and incident ASCVD by CAC burden among those at intermediate risk of ASCVD. Design, setting, and participants: The Multi-Ethnic Study of Atherosclerosis is a multicenter population-based prospective cross-sectional study conducted in the US. Baseline data for the present study were collected between July 15, 2000, and July 14, 2002, and follow-up for incident ASCVD events was ascertained through August 20, 2015. Participants were aged 45 to 75 years with no clinical ASCVD or diabetes at baseline, were at intermediate risk of ASCVD (≥7.5% to <20.0%), and had a low-density lipoprotein cholesterol level of 70 to 189 mg/dL. Exposures: Family history of premature ASCVD, premature menopause, metabolic syndrome, chronic kidney disease, lipid and inflammatory biomarkers, and low ankle-brachial index. Main outcomes and measures: Incident ASCVD over a median follow-up of 12.0 years. Results: A total of 1688 participants (mean [SD] age, 65 [6] years; 976 men [57.8%]). Of those, 648 individuals (38.4%) were White, 562 (33.3%) were Black, 305 (18.1%) were Hispanic, and 173 (10.2%) were Chinese American. A total of 722 participants (42.8%) had a CAC score of 0. Among those with 1 to 2 risk-enhancing factors vs those with 3 or more risk-enhancing factors, the prevalence of a CAC score of 0 was 45.7% vs 40.3%, respectively. Over a median follow-up of 12.0 years (interquartile range [IQR], 11.5-12.6 years), the unadjusted incidence rate of ASCVD among those with a CAC score of 0 was less than 7.5 events per 1000 person-years for all individual risk-enhancing factors (with the exception of ankle-brachial index, for which the incidence rate was 10.4 events per 1000 person-years [95% CI, 1.5-73.5]) and combinations of risk-enhancing factors, including participants with 3 or more risk-enhancing factors. Although the individual and composite addition of risk-enhancing factors to the traditional risk factors was associated with improvement in the area under the receiver operating curve, the use of CAC scoring was associated with the greatest improvement in the C statistic (0.633 vs 0.678) for ASCVD events. For incident ASCVD, the net reclassification improvement for CAC was 0.067. Conclusions and relevance: In this cross-sectional study, among participants with CAC scores of 0, the presence of risk-enhancing factors was generally not associated with an overall ASCVD risk that was higher than the recommended treatment threshold for the initiation of statin therapy. The use of CAC scoring was associated with significant improvements in the reclassification and discrimination of incident ASCVD. The results of this study support the utility of CAC scoring as an adjunct to risk-enhancing factor assessment to more accurately classify individuals with an intermediate risk of ASCVD who might benefit from statin therapy.
[Aganglionosis of the small intestine].

O. Knutrud

1971-03-31

Minerva Chirurgica

Abstract:
Coronary Artery Calcium Score Improves Risk Assessment of Symptomatic Patients in Low-Risk Group Based on Current Guidelines

Chengjian Wang,Xiaomeng Zhang,Chang Liu,Chao Zhang,Guolei Sun,Jia Zhou

DOI: https://doi.org/10.31083/j.rcm2406162

2023-06-06

Reviews in Cardiovascular Medicine

Abstract:Background: The guidelines for evaluation and diagnosis of stable chest pain (SCP) released by American societies in 2021 (2021 GL) and European Society of Cardiology (ESC) in 2019 both recommended the estimation of pretest probability (PTP) by ESC-PTP model. Further risk assessment for the low-risk group according to 2021 GL (ESC-PTP ≤15%) is important but still remains unclear. Thus, the present study intended to comprehensively investigate the diagnostic and prognostic value of coronary artery calcium score (CACS) in these low-risk patients. Methods: From January 2017 to June 2019, we initially enrolled 8265 patients who were referred for CACS and coronary computed tomography angiography (CCTA) for the assessment of SCP. PTP of each patient was estimated by ESC-PTP model. Patients with ESC-PTP ≤15% were finally included and followed up for major adverse cardiovascular event (MACE) and utilization of invasive procedures until June 2022. The degree of coronary artery disease (CAD) on CCTA was defined as no CAD (0%), nonobstructive CAD (1–49%) and obstructive CAD (≥50%). Multivariate Cox proportional hazards and Logistic regression models were used to calculate adjusted hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs), respectively. Results: A total of 5183 patients with ESC-PTP ≤15% were identified and 1.6% experienced MACE during the 4-year follow-up. The prevalence of no CAD and obstructive CAD decreased and increased significantly (p < 0.0001) in patients with higher CACS, respectively, and 62% had nonobstructive CAD among those with CACS >0, resulting in dramatically increasing ORs for any stenosis ≥50% and >0% across CACS strata. Higher CACS was also associated with an elevated risk of MACE (adjusted HR of 3.59, 13.47 and 6.58 when comparing CACS = 0–100, CACS >100 and CACS >0 to CACS = 0, respectively) and intensive utilization of invasive procedures. Conclusions: In patients for whom subsequent testing should be deferred according to 2021 GL, high CACS conveyed a significant probability of substantial stenoses and clinical endpoints, respectively. These findings support the potential role of CACS as a further risk assessment tool to improve clinical management in these low-risk patients.

cardiac & cardiovascular systems
Abstract 11370: Coronary Artery Calcium Incidence Varies by ASCVD Risk: Insights From the Dallas Heart Study

Anurag Mehta,Parag Joshi,Colby Ayers,Khurram Nasir,Jarett Berry,Anand Rohatgi,Amit Khera

DOI: https://doi.org/10.1161/circ.134.suppl_1.11370

IF: 37.8

2016-11-11

Circulation

Abstract:Introduction: Absence of coronary artery calcium (CAC=0) is associated with favorable cardiovascular outcomes and can be useful for down-classifying risk in middle-aged asymptomatic individuals. Identifying predictors of incident CAC can inform preventive measures. Hypothesis: We hypothesized that in a young, multi-ethnic, population-based cohort, increasing atherosclerotic cardiovascular disease (ASCVD) risk would be associated with incident CAC on repeat scanning. Methods: Participants of the Dallas Heart Study (DHS) underwent CAC scanning at baseline (EBCT) and at follow up (MDCT), after a mean interval of 6.9 years. Participants with baseline CAC=0 were included, and those with clinical ASCVD or on statin therapy were excluded. Incident CAC was analyzed as CAC >0 as well as CAC >10 at follow up. ASCVD risk was calculated using the 2013 AHA/ACC risk estimator. Results: Among 2,272 participants with baseline and follow up CAC measurements, 756 participants meeting exclusion criteria had absent CAC (CAC=0) at baseline, with a mean age of 42 years, 65.6% women, and 42.2% blacks. Of these individuals, incident CAC occurred in 23.8% using CAC >0 and in 8.3% using CAC >10. Risk markers associated with incident CAC >0 included baseline 10-year ASCVD risk, family history of coronary heart disease, low density lipoprotein particle concentration, diabetes and statin use at follow up. In fully adjusted analyses, only baseline 10-year ASCVD risk was associated with incident CAC >0. The prevalence of CAC >0 at follow up by baseline 10-year ASCVD risk categories of <5%, ≥5 to 7.5% was 21.2%, 41.5%, and 51.4%, respectively (p-trend 10 was 7%, 12.2%, and 27.1% respectively. Conclusions: In this young cohort, one in four individuals with absent CAC developed incident CAC after approximately 7 years. Reassessing risk, including consideration of repeat CAC measurement in those with higher baseline 10-year ASCVD risk, may be warranted.

cardiac & cardiovascular systems,peripheral vascular disease
Coronary Artery Calcification and Risk of Cardiac Complication in Geriatric Trauma Population

Sarah A King,Jacob D Jenkins,James Livesay,Ji-Ming Yune,Elizabeth Mannino,Jason M Webb,Haddon C Hill,Raj Baljepally,Brian J Daley,Lou M Smith

DOI: https://doi.org/10.1097/xcs.0000000000000945

2024-03-15

Journal of the American College of Surgeons

Abstract:BACKGROUND: Better means of identifying patients with increased cardiac complication (CC) risk is needed. Coronary artery calcification (CAC) is reported on routine chest CT scans. We assessed the correlation of CAC and CCs in the geriatric trauma population. STUDY DESIGN: A prospective, observational study of patients 55 years and older who had chest CT scan from May to September 2022 at a level 1 trauma center. Radiologists scored CAC as none, mild, moderate, or severe. None-to-mild CAC (NM-CAC) and moderate-to-severe CAC (MS-CAC) were grouped and in-hospital CCs assessed (arrhythmia, ST elevation myocardial infarction [STEMI], non-STEMI, congestive heart failure, pulmonary edema, cardiac arrest, cardiogenic shock, and cardiac mortality). Univariate and bivariate analyses were performed. RESULTS: Five hundred sixty-nine patients had a chest CT, of them 12 were excluded due to missing CAC severity. Of 557 patients, 442 (79.3%) had none-to-mild CAC and 115 (20.7%) has MS-CAC; the MS-CAC group was older (73.3 vs 67.4 years) with fewer male patients (48.7% vs 54.5%), had higher cardiac-related comorbidities, and had higher abbreviated injury scale chest injury scores. The MS-CAC group had an increased rate of CC (odds ratio [OR] 1.81, p = 0.016). Cardiac complications statistically more common in MS-CAC were congestive heart failure (OR 3.41, p = 0.003); cardiogenic shock (OR 3.3, p = 0.006); non-STEMI I or II (OR 2.8, p = 0.017); STEMI (OR 5.9, p = 0.029); and cardiac-caused mortality (OR 5.27, p = 0.036). No statistical significance between pulmonary edema (p = 0.6), new-onset arrhythmia (p = 0.74), or cardiac arrest (p = 0.193). CONCLUSIONS: CAC as reported on chest CT scans demonstrates a significant correlation with CC and should warrant additional cardiac monitoring.

surgery
Progression of coronary artery calcium density and major adverse cardiovascular events

Qingchao Meng,Li Zhao,Na Zhao,Yunqiang An,Bin Lu,Yang Gao

DOI: https://doi.org/10.1016/j.atherosclerosis.2024.118593

IF: 5.3

2024-09-08

Atherosclerosis

Abstract:Background and aims To investigate the relationship between coronary artery calcium (CAC) density progression and major adverse cardiovascular events (MACE), and the prognostic value of CAC density progression. Methods Patients with serial CAC scans were enrolled in this study. The CAC density was directly measured by in calcified lesions. The change and rate of progression of CAC density were calculated. Cox proportional hazard regression was utilized to estimate hazard ratios (HRs) for time to MACE regarding CAC density. The incremental prognostic value and the reclassification ability of CAC density progression were evaluated using the C-index and continuous net reclassification index (NRI). Results 304 patients (57.86±9.47 years, 69.4% male) were included. There was 47 MACE over a follow–up period of 76.00 (56.00–95.00) months. Adjusted for risk factors and CAC volume, the change of CAC density was inversely associated with MACE (per 10HU: HR: 0.956, 95% confidence interval: 0.920–0.992, p = 0.018). Adding the change of CAC density to risk factors and the baseline CAC density improved the C-index (0.694 vs. 0.678, p = 0.026). Adding the change of CAC density improved reclassification of MACE compared with risk factors and the baseline CAC density [NRI = 0.432 (0.016–0.789)]. Conclusions CAC density progression was inversely associated with MACE. The addition of the change of CAC density improves prognostic value compared to baseline risk factors and CAC density and optimizes risk reclassification.

cardiac & cardiovascular systems,peripheral vascular disease

Does itraconazole improve quality of life in severe asthma with fungal sensitization?

Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial

Coronary Artery Calcium for Risk Stratification Among Persons With Very High HDL Cholesterol

Association between coronary artery calcium score on non-contrast chest computed tomography and all-cause mortality among patients with congestive heart failure

The utility of coronary artery calcium in non-gated high resolution CT thorax scans in predicting cardiac events as compared to the Framingham risk score: a retrospective study

Interplay between Risk Factors and Coronary Artery Calcium in Middle-Aged and Elderly Symptomatic Patients

Electrohydraulic waves (Urat I) for the treatment of vesical calculi

The role of coronary artery calcium score and european score2 in primary prevention of cardiovascular disease

Non-esterified fatty acids, serum insulin and blood glucose after a beta-receptor blocking agent in normal, hypophysectomized, diabetic and hypophysectomized-diabetic dogs.

Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in Coronary Artery Calcium >1,000

Comparative Value of Coronary Artery Calcium and Multiple Blood Biomarkers for Prognostication of Cardiovascular Events

Synaptic processes in motor neurons during viscero-somatic reflexes

Coronary artery calcium as a marker of healthy and unhealthy aging in adults aged 75 and older: The atherosclerosis risk in communities (ARIC) study

Impact of coronary artery calcium on mortality and cardiovascular events in metabolic syndrome and diabetes among younger adults

Association between coronary artery calcification score as assessed by multi-detector row computed tomography and cardiovascular risk factors

Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis

[Aganglionosis of the small intestine].

Coronary Artery Calcium Score Improves Risk Assessment of Symptomatic Patients in Low-Risk Group Based on Current Guidelines

Abstract 11370: Coronary Artery Calcium Incidence Varies by ASCVD Risk: Insights From the Dallas Heart Study

Coronary Artery Calcification and Risk of Cardiac Complication in Geriatric Trauma Population

Progression of coronary artery calcium density and major adverse cardiovascular events